Press release
Global Endocrinology Drugs Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Endocrinology Drugs Market
How Big Is the Endocrinology Drugs Market Size Expected to Be by 2034?
The market size for endocrinology drugs has witnessed robust growth in the past few years. It is expected to expand from $33.26 billion in 2024 to $36.21 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.86%. The historical growth is mainly due to the rising global incidence of diabetes, increased government interventions, growing health care spending, enhanced occurrence of adrenal gland disorders, heightened demand for insulin analogs, and an increase in the quantity of endocrinologists.
The market size for endocrinology drugs is projected to experience robust growth in the forthcoming years. The evaluation estimates a growth to reach $50.37 billion by 2029 with a compound annual growth rate (CAGR) of 8.60%. Factors contributing to this projected growth in the forecast period include a surge in the diabetic population, a rise in the frequency of endocrine disorders, an increase in the count of teenagers dealing with hormonal imbalances, and escalating obesity rates. Throughout this forecast period, considerable trends to watch include technological progress, the application of sophisticated drug delivery systems, the incorporation of digital health solutions, precision medicine, and combined treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20769
What Are the Emerging Segments Within the Endocrinology Drugs Market?
The endocrinology drugs market covered in this report is segmented -
1) By Indication: Hyperthyroidism, Hypothyroidism, Diabetes, Polycystic Ovarian Syndrome, Growth Hormone Disorders, Pituitary Gland Disorders, Other Indications
2) By Therapy Area: Diabetes Drugs, Thyroid Hormone Disorder Drugs, Human Growth Hormone, Testosterone Replacement Therapy, Others Therapy Areas
3) By Distribution Channel: Hospital pharmacies, Online Pharmacies, Retail pharmacies
4) By End User: Hospitals, Ambulatory Surgical Centers, Others End Users
Subsegments:
1) By Hyperthyroidism: Antithyroid Medications, Radioactive Iodine Therapy, Beta Blockers
2) By Hypothyroidism: Levothyroxine-based Medications, Liothyronine-based Medications, Combination Hormonal Therapies
3) By Diabetes: Insulin Therapies, Oral Antidiabetic Drugs (OADs), GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors
4) By Polycystic Ovarian Syndrome (PCOS): Oral Contraceptives, Metformin, Clomiphene Citrate, Anti-Androgens
5) By Growth Hormone Disorders: Recombinant Human Growth Hormone (rhGH), Growth Hormone Secretagogues, Growth Hormone Receptor Antagonists
6) By Pituitary Gland Disorders: Somatostatin Analogs, Gonadotropins, Dopamine Agonists
7) By Other Indications: Adrenal Gland Disorders, Osteoporosis, Parathyroid Disorders, Male Hormonal Imbalances
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20769&type=smp
What Long-Term Drivers Are Shaping Endocrinology Drugs Market Trends?
The increase in endocrine diseases is predicted to boost the expansion of the endocrinology drugs market. These diseases, which disrupt the endocrine system leading to hormonal imbalances that affect normal bodily processes, are on the rise due to various reasons such as alterations in lifestyle, an aging populace, and enhanced diagnosis. These factors have led to a heightened awareness and occurrence of these conditions. Endocrinology medications assist in managing these diseases by regulating hormone levels, treating glandular dysfunction, and reestablishing hormonal equilibrium to relieve symptoms and improve overall health. For example, the National Library of Medicine reported in May 2023 that about 13 million people, or 4.78% of the population in the United States, are suffering from unidentified endocrine disorders. Thyroid disease, which accounts for approximately 30% to 40% of patients in endocrine practices, is one of the most common among these. Thus, the escalating prevalence of endocrine diseases is fueling the growth of the endocrinology drugs market.
Who Are the Top Competitors in Key Endocrinology Drugs Market Segments?
Major companies operating in the endocrinology drugs market are Johnson & Johnson Inc., Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Novartis International AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Biocon Limited, Boehringer Ingelheim International GmbH, Mylan N.V., Sandoz International GmbH, Ipsen Pharma, Ferring Pharmaceuticals Inc., Endocrine Pharma Private Limited
What Actigraphy Devices Market Trends Are Gaining Traction Across Different Segments?
Renowned companies in the endocrinology drugs industry are concentrating on the creation of innovative offerings such as ready-to-use vials to enhance the process of administering medication. These vials, pre-filled and pre-dosed, do not need any kind of reconstitution or preparation prior to administration. For example, in December 2022, Hikma Pharmaceuticals plc, a pharmaceutical company based in the UK, unveiled their Levothyroxine sodium injection in ready-to-use vials, with a concentration of 100 mcg/mL. The formulation is intended to be used immediately, helping eliminate reconstitution needs and minimize preparation errors, which in turn, boons patient safety. It warrants precise and steady dosing, a key element for managing medical issues such as hypothyroidism and myxedema coma. The ready-to-use vials also boost efficiency for medical professionals, saving precious time and ensuring the correct administration in urgent care scenarios.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/endocrinology-drugs-global-market-report
Which Regions Are Becoming Hubs for Endocrinology Drugs Market Innovation?
North America was the largest region in the endocrinology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrinology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Endocrinology Drugs Market?
2. What is the CAGR expected in the Endocrinology Drugs Market?
3. What Are the Key Innovations Transforming the Endocrinology Drugs Industry?
4. Which Region Is Leading the Endocrinology Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Endocrinology Drugs Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 4067099 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
